Infratemporal Fossa Approach Workup

  • Author: Ricardo L Carrau, MD, FACS; Chief Editor: Arlen D Meyers, MD, MBA   more...
 
Updated: Mar 27, 2012
 

Imaging Studies

CT scan and MRI provide important and complementary information. A CT scan better depicts the remodeling or erosion of the bony skull base. An MRI better depicts the soft-tissue planes (including the interface of the tumor and soft tissues) and the presence of perineural and perivascular tumor. Images of both coronal and axial view MRI depicting a V3 neurilemoma are seen below. Both CT scan and MRI with contrast can be used to ascertain the relationship of the tumor to the ICA.

Coronal view MRI depicting a V3 neurilemoma. Coronal view MRI depicting a V3 neurilemoma. Axial view MRI depicting V3 neurilemoma of the infAxial view MRI depicting V3 neurilemoma of the infratemporal fossa.

MR angiography (MRA) and CT angiography (CTA) are noninvasive tests that demonstrate the arterial anatomy of the ITF and brain. Angiography is preferred over MRA and CTA when preoperative embolization of the tumor is indicated (eg., juvenile nasopharyngeal angiofibromas [JNA], paragangliomas). Angiography identifies the vascularity of the tumor and its relationship to the ICA and demonstrates the cerebral circulation and its collateral vasculature. Neither of these anatomical tests, however, predicts the adequacy of the intracranial collateral blood supply after sacrifice of the ICA.

Collateral blood supply to the brain is better evaluated using single-photon emission computed tomography (SPECT) with balloon occlusion, transcranial Doppler, or angiography and balloon occlusion with xenon-enhanced computed tomography (ABOX-CT) scan. These tests predict the probability of cerebral ischemia when the ipsilateral ICA is sacrificed and, therefore, are indicated when the risk for injury or the need for sacrifice of the ICA is high. Although technically and logistically the ABOX-CT scan is more complex than other alternative tests, the authors prefer the ABOX-CT scan due to its superior sensitivity and specificity.

  • During the ABOX-CT scan, a catheter with a non-detachable balloon is inserted in the ICA via the femoral artery. The balloon is inflated for 15 minutes, while the awake patient is monitored for any neurological deficit. Any neurological deficit warrants cessation of the test and places the patient in a high-risk category.
  • If no deficits develop, the balloon is deflated, and the patient is transferred to a CT scan suite. A mixture of 32% xenon and 68% oxygen is administered via facial mask for 4 minutes. CT scan demonstrates the cerebral distribution of xenon, which reflects the blood flow and, thus, provides a quantitative assessment measured as cubic centimeters (cm3) of blood flow per minute per 100 grams of brain tissue (cm3/min/100 g).
  • The process then is repeated after the ICA is occluded by inflation of the balloon. Special software calculates the differential of the xenon diffusion in the brain before and after balloon inflation. Using this information, the authors identify those patients at risk for an ischemic injury after sacrifice of the ipsilateral ICA.
  • Remember, however, that patients can suffer a stroke due to embolic phenomena or the loss of collateral vessels in watershed areas that are not assessed by balloon occlusion testing.
  • In addition, recognize that the ABOX-CT scan is performed under ideal and controlled circumstances and does not account for possible episodes of hypoxia, hypotension, or electrolyte- or acid-base disturbances, which may alter brain hemodynamics. Some have advocated the use of hypotension to increase the sensitivity of the test. In any event, preservation of the ICA is a preferred option.
Next

Diagnostic Procedures

Whenever possible, obtain a histological diagnosis before the extirpative surgery. Most tumors are amenable to punch or open biopsy. Some tumors (eg, angiofibromas, some neurilemomas) can be diagnosed based on their clinical and imaging characteristics. Tumors in the deeper planes may be sampled by FNAB. In the rare instance that an adequate biopsy cannot be obtained, a frozen section analysis may be obtained via a skull-base approach, preferably endoscopic. If the histological diagnosis can be established with a reasonable degree of confidence, the tumor may be resected within the same surgery. Consider, however, that frozen section analysis is not without limitation. Thus, sacrifice of critical neurovascular structures (eg, ICA, orbit, CNs) based solely on a frozen section analysis is not prudent. A staged procedure after reviewing permanent pathology sections with the pathology team is favored in these instances.

Previous
Next

Staging

The staging evaluation is tailored to the histological type, extent, and site origin of the tumor. A CT scan of the neck is recommended to rule out regional lymphadenopathy. Patients with tumors that metastasize hematogenously (eg, sarcoma, melanoma, adenoid cystic, neuroendocrine) should undergo a PET/CT scan of the chest and abdomen and pelvis. A lumbar spinal tap for cerebrospinal fluid (CSF) cytology and a spinal MRI to rule out "drop metastasis" and carcinomatosis are recommended for patients who have parameningeal malignancies.

Previous
 
 
Contributor Information and Disclosures
Author

Ricardo L Carrau, MD, FACS  Professor, Department of Otolaryngology-Head and Neck Surgery, Director of the Comprehensive Skull Base Surgery Program, The Ohio State University Medical Center

Ricardo L Carrau, MD, FACS is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Laryngological Association, American Medical Association, American Rhinologic Society, American Society for Head and Neck Surgery, North American Skull Base Society, Pennsylvania Medical Society, and Triological Society

Disclosure: Nothing to disclose.

Coauthor(s)

Amol M Bhatki, MD  Attending Physician, Department Of Otolaryngology–Head and Neck Surgery, Co-Director of Skull Base Center, Baylor University Medical Center at Dallas

Amol M Bhatki, MD is a member of the following medical societies: Alpha Omega Alpha and American Rhinologic Society

Disclosure: Nothing to disclose.

Daniel M Prevedello, MD  Assistant Professor, Department of Neurological Surgery, Ohio State University Medical Center

Disclosure: Nothing to disclose.

Amin B Kassam, MD  Consulting Surgeon, The Ottawa Hospital

Amin B Kassam, MD is a member of the following medical societies: American Association of Neurological Surgeons and Ontario Medical Association

Disclosure: Karl Storz Endoscopy Consulting fee Consulting; Stryker Instruments Consulting fee Consulting; NICO Corporation Equity stake Board membership

Specialty Editor Board

Douglas D Backous, MD  Director of Listen for Life Center, Department of Otolaryngology-Head and Neck Surgery, Virginia Mason Medical Center

Douglas D Backous, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American College of Surgeons, American Laryngological Rhinological and Otological Society, American Medical Association, Association for Research in Otolaryngology, North American Skull Base Society, Society for Neuroscience, and Washington State Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Nader Sadeghi, MD, FRCSC  Professor, Otolaryngology-Head and Neck Surgery, Director of Head and Neck Surgery, George Washington University School of Medicine and Health Sciences

Nader Sadeghi, MD, FRCSC is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society, American Thyroid Association, and Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Christopher L Slack, MD  Private Practice in Otolaryngology and Facial Plastic Surgery, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders

Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA  Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society

Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation Unrestricted gift Unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Medvoy Ownership interest Management position; Cerescan Imaging Consulting; Headwatersmb Consulting fee Consulting; Venturequest Royalty Consulting

Additional Contributors

Carl H Snyderman, MD Professor, Departments of Otolaryngology and Neurological Surgery, University of Pittsburgh Medical Center

Carl H Snyderman, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Society for Head and Neck Surgery, North American Skull Base Society, Pennsylvania Medical Society, Phi Beta Kappa, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Phacon Consulting fee Consulting

References
  1. Barbosa JF. Surgery of extensive cancer of paranasal sinuses. Presentation of a new technique. Arch Otolaryngol. Feb 1961;73:129-38. [Medline].

  2. Sekhar LN, Schramm VL Jr, Jones NF. Subtemporal-preauricular infratemporal fossa approach to large lateral and posterior cranial base neoplasms. J Neurosurg. Oct 1987;67(4):488-99. [Medline].

  3. Janecka IP, Sen CN, Sekhar LN, Arriaga M. Facial translocation: a new approach to the cranial base. Otolaryngol Head Neck Surg. Sep 1990;103(3):413-9. [Medline].

  4. Cocke EW Jr, Robertson JH, Robertson JT, Crook JP Jr. The extended maxillotomy and subtotal maxillectomy for excision of skull base tumors. Arch Otolaryngol Head Neck Surg. Jan 1990;116(1):92-104. [Medline].

  5. Judson BL, Adam S, Lowlicht R, Bulsara KR. Transcervical Double Mandibular Osteotomy Approach to the Infratemporal Fossa. World Neurosurg. Dec 13 2011;[Medline].

  6. Catalano PJ, Biller HF. Extended osteoplastic maxillotomy. A versatile new procedure for wide access to the central skull base and infratemporal fossa. Arch Otolaryngol Head Neck Surg. Apr 1993;119(4):394-400. [Medline].

  7. Mishra A. Transorbital approach to infratemporal fossa: novel technique. J Laryngol Otol. Jun 2011;125(6):638-42. [Medline].

  8. Fisch U. The infratemporal fossa approach for the lateral skull base. In: The Otolaryngologic Clinics of North America. Philadelphia, Pa: WB Saunders Co; 1984:513-552.

  9. Terz JJ, Young HF, Lawrence W Jr. Combined craniofacial resection for locally advanced carcinoma of the head and neck II. Carcinoma of the paranasal sinuses. Am J Surg. Nov 1980;140(5):618-24. [Medline].

  10. Biller HF, Shugar JM, Krespi YP. A new technique for wide-field exposure of the base of the skull. Arch Otolaryngol. Nov 1981;107(11):698-702. [Medline].

  11. Bilsky MH, Bentz B, Vitaz T, Shah J, Kraus D. Craniofacial resection for cranial base malignancies involving the infratemporal fossa. Neurosurgery. Oct 2005;57(4 Suppl):339-47; discussion 339-47. [Medline].

  12. Carrau RL, Pou A, Eibling DE, Murry T, Ferguson BJ. Laryngeal framework surgery for the management of aspiration. Head Neck. Mar 1999;21(2):139-45. [Medline].

  13. Fortes FS, Carrau RL, Snyderman CH, et al. Transpterygoid transposition of a temporoparietal fascia flap: a new method for skull base reconstruction after endoscopic expanded endonasal approaches. Laryngoscope. Jun 2007;117(6):970-6. [Medline].

  14. Fortes FS, Sennes LU, Carrau RL, et al. Endoscopic anatomy of the pterygopalatine fossa and the transpterygoid approach: development of a surgical instruction model. Laryngoscope. Jan 2008;118(1):44-9. [Medline].

  15. Hadad G, Bassagasteguy L, Carrau RL, et al. A novel reconstructive technique after endoscopic expanded endonasal approaches: vascular pedicle nasoseptal flap. Laryngoscope. Oct 2006;116(10):1882-6. [Medline].

  16. Kassam AB, Gardner P, Snyderman C, Mintz A, Carrau R. Expanded endonasal approach: fully endoscopic, completely transnasal approach to the middle third of the clivus, petrous bone, middle cranial fossa, and infratemporal fossa. Neurosurg Focus. Jul 15 2005;19(1):E6. [Medline].

  17. Kassam AB, Gardner P, Snyderman C, Mintz A, Carrau R. Expanded endonasal approach: fully endoscopic, completely transnasal approach to the middle third of the clivus, petrous bone, middle cranial fossa, and infratemporal fossa. Neurosurg Focus. Jul 2005;19(1):E6.

  18. Mansour OI, Carrau RL, Snyderman CH, Kassam AB. Preauricular infratemporal fossa surgical approach: modifications of the technique and surgical indications. Skull Base. Aug 2004;14(3):143-51; discussion 151. [Medline].

  19. Netterville JL, Jackson CG, Civantos F. Thyroplasty in the functional rehabilitation of neurotologic skull base surgery patients. Am J Otol. Sep 1993;14(5):460-4. [Medline].

  20. Nuss DW, Janecka IP, Sekhar LN, Sen CN. Craniofacial disassembly in the management of skull-base tumors. Otolaryngol Clin North Am. Dec 1991;24(6):1465-97. [Medline].

  21. Pou AM, Carrau RL, Eibling DE, Murry T. Laryngeal framework surgery for the management of aspiration in high vagal lesions. Am J Otolaryngol. Jan-Feb 1998;19(1):1-7. [Medline].

  22. Sekhar LN, Sen C, Snyderman CH. Anterior, anterolateral, and lateral approaches to extradural petroclival tumors. In: Sekhar LN, Janecka IP, eds. Surgery of Cranial Base Tumors. NY: Raven Press; 1993:157-223.

  23. Snyderman CH, Carrau RL, deVries EJ. Carotid artery resection: Update on preoperative evaluation. In: Johnson JT, Derkay CS, Mandell-Brown MK, Newman RK, eds. AAO-HNS Instructional Courses. 1993:341-346.

Previous
Next
 
Coronal view MRI depicting a V3 neurilemoma.
Axial view MRI depicting V3 neurilemoma of the infratemporal fossa.
Bicoronal incision with preauricular extension.
The superficial layer of the deep temporal fascia has been incised, revealing the temporal fat pad.
Exposure of orbitozygomatic complex.
Depiction of possible orbitozygomatic osteotomies.
Skull base relationships. The lateral pterygoid plate, foramen ovale, and the foramen spinosum are depicted in a straight-line relationship from anterior to posterior. The carotid canal is posterior and medial to these structures.
A temporal craniotomy and osteotomy for condylectomy and coronoidectomy.
From posterior to anterior (left to right), internal carotid artery (petrous), middle meningeal artery, V3, and V2.
Intraoperative photograph after a total parotidectomy, segmental mandibulectomy, and infratemporal fossa resection.
Markings depicting the facial incisions for a facial translocation approach.
Exposure of the maxillary and orbitozygomatic areas.
Osteotomies.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.